Dabrafenib Archives - Medical Conferences

Dabrafenib plus trametinib candidates for standard-of-care in BRAF V600-mutated paediatric low-grade glioma

Presented By

Prof. Eric Bouffet, University of Toronto, Canada

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 15:30

Higher response rates for concurrent triple therapy versus sequential therapy in melanoma

Presented By

Prof. Georgina Long, The University of Sydney, Australia

Trial

Phase 2, NeoTrio

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 13:50

ASCO 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

ASCO 2022

21 June 2022 09:38

Immuno-combination therapy in metastatic melanoma

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:52

Will malignant melanoma become a curable disease?

Presented By

Prof. Claus Garbe; Prof. Caroline Robert

Trial

COMBI-d, COMBI-v, COMBI-i, KEYNOTE-001

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 20:46

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com